It is estimated that one in every person half dozen is allergic to certain foods or sensitive, and that many health, psychological and behavioral problems with food allergies. However, standard test strategies do not typically stains allergies allergy patients.

I see a lot of patients who have spent many frustrating years trying to understand their health problems, just to get that they are, in fact, have food allergies. Not surprisingly, a large number of these patients or children with allergies say tell me that 1 suspect allergies, but their suspicions were dismissed by their doctors, when the test results showed negative. It is due to the persistence of these patients to find the answers they sought.

Types of food allergies

A food allergy may trigger a response right away food or delayed. This, and if the reaction involves antibody levels determine the type of food allergy.

Order l. immediately or later eating the food, you have symptoms clear and dramatic. If you are allergic to mushroom, may develop abdominal cramps and less than an hour of eating one mushroom stew. A child with a response of type 1 Kiwi can suffer severe itching in the mouth or vomiting at intervals of 15 minutes to eat a kiwi.

Type an end allergy with high levels of IgE-antibodies in the blood so that they are merely diagnosed by testing for these antibodies. Many doctors consider IgE mediated allergies to be the only true allergies, however, most food allergies are mediated by Ige. Only 3-5% of young people and 1-2% of adults are estimated to be plagued by allergies type l.

Anaphylaxis-a severe reaction that can be fatal in minutes – can be a response of type 1. Warning signs are dizziness, light-dizziness, swollen or throat, trouble breathing, fainting, or edema immediately after consumption. Get immediate emergency assistance.

Sorting ll. Although not considered a true allergy doctors extra conservative reaction type ll still eventually antibody levels, sometimes IgA, IgG and IgM, inflammatory reactions.

Type LLL. Delayed reactions often go unrecognized because symptoms don’t seem to be generally obvious and could occur days after the food is consumed. Jointly, since they contain no IgE antibody, allergic reactions to delay will not appear on the usual skin tests or blood tests. Instead, they show that physical symptoms, behavioral and learning cluster which affect many body systems at a time. Type lll allergies are for this reason, usually called “hidden” allergies.

A person suffering from food allergies applicant type lll suffer shortness of breath, throat mucousy, sporadic emotional swings and hyperactivity, chronic nasal congestion and flu-like symptoms. For another person, symptoms will embody headache, itchy eyes, abdominal pain, depression, fatigue, sleep disorders and swollen lymph nodes.

These models of delayed reaction allergy are annoying diagnose. Health professionals believe that they represent for many food allergies, particularly among children. Individually, no matter which model undefined illness that involves completely different symptoms and symptoms completely different body must be taken as a sign apparently food allergy until proven otherwise.

Effective tests for food allergies

Given the prevalence of food allergies type lll, different screening strategies are called for. The most common are not regulars that watch is that the rotation diet. Common food allergens food allergens suspects eliminated from the diet for 4-7 days and are then reintroduced. When the body is given the likelihood of further food allergens, symptoms will usually subside or disappear. Reintroduced once more food, cause symptoms reappear, allowing you to simply identify what foods are interested in.

Kinesthetic and power test

Several therapists natural control for allergies, identifying the power cut caused by completely different foods. Somehow works on the principle that these disorders can briefly weakening of the muscles of the body, while others use the energy technology to identify what foods cause disturbances in the energy fields of the organization. Though still not accepted as valid test by medicine standard, these means tests involve thousands of patients whose innovations allergies went previously undiagnosed.

Duong (pronounced Yung) might be a holistic doctor with some further qualifications in nutrition and environmental medicine, phytotherapy, anti-aging drugs, acupuncture, energy medicine and Biomesotherapy. It utilizes the resources of its talented team, a full range of modalities and innovative medical technologies that enable solutions to produce optimal health and well-being in mind, body and spirit in its two clinics in Brisbane and Gold Coast.

Interests of Duong hug anti-aging drugs, biological-identical hormones adrenal and thyroid dysfunction, emotional health and advanced allergy elimination. With its seventeen years of experience dealing with chronically ill patients, she knows that many chronic diseases and autoimmune disorders have underlying hidden allergies or intolerances.

Diabetes is one of the deadliest diseases, which is also known under the name of a metabolic disorder. It occurs because of a greater amount of blood glucose level. While insulin is a hormone that is produced by the body called the pancreas to provide energy, what we can do various activities like playing, running, etc. Most people have no idea of what type of diabetes, so it is strongly recommended to go for your own body check-up to identify the type of diabetes. There are different types of diabetes, but here are the most common types:

Type 1: patients with type 1 diabetes usually require insulin injections or pump, can occur due to any virus or any other disturbance. In this type of diabetes, the body finds it difficult to recognize related organs and the attacks against it. People who are under the age of 40 are generally diagnosed of this type.

Type 2: less courses, overweight and obesity are major causes of type 2 diabetes. When the pancreas is unable to produce sufficient amounts of insulin, this condition is converted to the disease known as type 2 diabetes. Treatment of type 2 diabetes also requires regular training walk in the morning and a healthy diet, as green vegetables, oatmeal or other foods rich in fibre.

According to recent research, diabetes is one of the most frequent reasons for number of deaths in us maxim. Here are some tips to get rid of this deadly disease:

Physical activity: people who are less physically active are more prone to diabetes than those who exercised regularly. We recommend that you go for a 30-45 minute brisk walk every day, it is useful to reduce the amount of extra calories the body.

Reduce the consumption of alcohol: it is better to reduce the consumption of alcohol, because it is processed similar to body fat, as he has a lot of calories. Therefore, it can raise the glucose in your body, the best way would be to drink moderately or should be limited to only a couple of times. Campralis the latest medication for the treatment of alcoholism.

Viral infections: sleep disorder or sleep disorders and other viral infections are also one of the reasons commonly known to the disturbance of insulin in the body. A drug called Imunovir can be used as a treatment of acute or chronic viral infection.

These measures of diabetes will help you get the best understanding of diabetes, which can be used as a preventive measure.

Hypertension, also termed high blood pressure, is a medical condition where the blood pressure is chronically elevated. Although symptomless in nature and in itself rarely an acute problem, persistent hypertension is one of the most important preventable causes of premature death worldwide and contributes to around half of all cardiovascular diseases. It is one of the major risk factors for stroke, myocardial infarction, heart failure, and vascular disease, and is a leading cause of chronic renal failure.

In hypertensionsystemic arterial blood pressure is elevated and it is the opposite of hypotension. Hypertension is classified as either primary (essential) hypertension or secondary hypertension; about 90–95% of cases are termed primary hypertension, which refers to high blood pressure for which no medical cause has been found (1).The remaining 5– 10% of cases (Secondary hypertension) are caused by other conditions that affect the kidneys, arteries, heart, or endocrine system. Persistent hypertension is one of the risk factors for stroke, myocardial infarction, heart failure and arterial aneurysm, and is a leading cause of chronic kidney failure. Moderate elevation of arterial blood pressure leads to shortened life expectancy. Dietary and lifestyle changes can improve blood pressure control and decrease the risk of associated health complications, although drug treatment may prove necessary in patients for whom lifestyle changes prove ineffective or insufficient. The development of a vaccine for the treatment of hypertension is now of similar importance as hypertension is one of the major causes of disease of the cardiovascular system and thus one of the most frequent causes of disease-induced deaths worldwide (1).

The World Health Organization attributes hypertension, or high blood pressure, as the leading cause of cardiovascular mortality. The World Hypertension League (WHL), an umbrella organization of 85 national hypertension societies and leagues, recognized that more than 50% of the hypertensive population worldwide is unaware of their condition (2). To address this problem, the WHL initiated a global awareness campaign on hypertension in 2005 and dedicated May 17 of each year as World Hypertension Day (WHD). Over the past three years, more national societies have been engaging in WHD and have been innovative in their activities to get the message to the public. In 2007, there was record participation from 47 member countries of the WHL. During the week of WHD, all these countries – in partnership with their local governments, professional societies, nongovernmental organizations and private industries – promoted hypertension awareness among the public through several media and public rallies. Using mass media such as Internet and television, the message reached more than 250 million people. As the momentum picks up year after year, the WHL is confident that almost all the estimated 1.5 billion people affected by elevated blood pressure can be reached (3).

Genetic predisposition and lifestyle habits such as inadequate physical activity, high fat diet, and high salt intake promote high blood pressure. Up to 30% of adults in most countries suffer from hypertension. Despite effective and relatively inexpensive treatment available, less than one out of four hypertensive individuals have their blood pressure controlled successfully (4). This poor overall treatment success is mainly attributed to the symptomless nature of hypertension and the necessity for long-term treatment with currently available medications that require at least once daily self administration.

Ambulatory blood pressure, blood pressure measured by numerous readings over a 24-hour period or longer, provides accurate and reliable information about a person’s blood pressure.

Angiotensin II, a small peptide which is part of the renin-angiotensin system (RAS). It induces narrowing of blood vessels and other effects to raise blood pressure. Diastolic blood pressure is the lowest pressure within the arterial blood stream occurring with each heart beat. Systolic blood pressure is the highest pressure within the arterial blood stream occurring with each heart beat (4).

The 2007 United States Preventive Services Task Force (USPSTF) guidelines on screening for high blood pressure recommended screening every two years for persons with systolic and diastolic pressures below 120 mmHg and 80 mmHg, respectively, and yearly for persons with a systolic pressure of 120 – 139 mmHg or a diastolic pressure of 80 – 89 mmHg (1). Hypertension can be classified according to its primary or secondary causes. The majority of patients (90%) suffer from primary hypertension, which many experts now believe is a multi-factorial disease. These factors include increased salt intake, reduced nephron mass, abnormal renin-angiotensin system, increased sympathetic tone and endothelial dysfunction. In contrast, secondary hypertension is associated with a single definable physiological dysfunction (primary kidney disease, renovascular disease, endocrine abnormality, sleep apnea, or coarctation of the aorta) and, thus, definitive treatment options may exist (1). Despite remarkable advances in new medications, the prevalence of hypertension continues to rise. From 1994 to 2004, increased public awareness of hypertension led to an increase in earlier diagnosis and treatment success. Unfortunately, approximately 30% of adults are believed to be unaware of their hypertension status, while 60% of individuals with hypertension are receiving the appropriate treatments and only 35% of patients have their blood pressure adequately controlled to less than 140/90 mmHg (from National Health and Nutrition Examination Survey (NHANES) data 1999 to 2004). The principal reasons associated with these dismal numbers are inadequate access and low compliance with treatments. One investigation reported that 11% of their patient cohort was non-compliant in adhering to an anti-hypertensive medication for more than 2 weeks (1). Therefore, improving patients’ compliance should be a primary goal for any new antihypertensive agents.

A hypertension vaccine could be an important alternative to conventional drug therapy because of patients’ inconsistent drug intake – if further research supports results from a small study testing the safety and tolerability of a vaccine. Juerg Nussberger, M.D., professor of medicine at the University Hospital of the Canton of Vaud, in Lausanne, Switzerland, and lead author of the study reported at the American Heart Association’s Scientific Sessions 2007 said that despite the fact that effective drugs are available, only about one out of four people has their blood pressure successfully controlled. Many patients are apparently unable or unwilling to take pills every day for the rest of their lives. If it could be added or substituted a vaccine that would need to be given just every few months, better control of high blood pressure could be achieved (5).

Vaccine against hypertension is an innovative treatment, injected every 4 – 6 months, to combat non-compliance. The pathogenesis of hypertension is multifactorial. Renin-angiotensin system (RAS) is important system in the body that regulates blood pressure. The most common cause is disruption of the Renin–angiotensin—aldosterone system (RAAS) and the first vaccine study was carried out against renin. While the vaccine reduced blood pressure in animal models, it also caused autoimmune disease. In the last decade, vaccines against angiotensin I, angiotensin II, and angiotensin II-type 1 receptors have demonstrated acceptable safety profiles in animal and human studies. Reduction in blood pressure can be achieved by inducing immunity against targets in the RAAS. The target antigen and selection of adjuvant are crucial factors determining effectiveness and safety of the vaccine. CYT006-AngQb (angiotensin II vaccine) reduced blood pressure in humans but the results were not reproducible with more frequent dosing. Vaccines for hypertension are still in the early phase. They hope for an effective vaccine for hypertension in the years to come (6).

The vaccine targets angiotensin II, a molecule that constricts blood vessels and raises blood pressure. Angiotensin II is already the indirect target of several blood pressure medications. Angiotensin-converting enzyme (ACE) inhibitors (such as benazapril and enalapril) reduce the production of angiotensin II in the blood by slowing its conversion from angiotensin I. Angiotensin receptor blockers (ARBs, such as candesartan and losartan) prevent angiotensin II from acting on these receptors, thus preventing constriction of the blood vessels. Martin Bachmann, Ph.D., senior co-author of the study and chief scientific officer at Cytos Biotechnology AG in Zurich, companies that create vaccines to treat and prevent chronic diseases, said that instead, they take non-infectious particles with a virus shape and chemically couple them with angiotensin II so the body begins to vigorously attack angiotensin II. To assess the antibody response and identify an effective dose of the vaccine (CYT006-AngQb), 72 patients with mild-tomoderate high blood pressure were injected with either 100 or 300 micrograms (ug) of the vaccine or a placebo. The patients included 65 men and seven women, average age 51.5 years old. After injections at zero, four and 12 weeks from the start of the study, patients who received the vaccine had a strong antibody response against angiotensin II, which was significantly higher in those receiving the higher dose. Blood pressure changes were evaluated at week 14. Compared with patients who received a placebo, those who were injected with 300ug of vaccine significantly reduced their daytime systolic blood pressure (the top number of a blood pressure reading, measuring pressure as the heart constricts) by 5.6 millimeters of mercury (mm Hg) and their diastolic blood pressure (the bottom number of a blood pressure reading, measuring pressure as the heart rests between beats) by 2.8 mm Hg. Their vaccine had the most striking effect early in the morning, the most dangerous time to have high blood pressure because it raises the risk of heart attack and stroke, (5).

Unlike vaccines generated against bacteria and viruses, a specific target antigen, anti-hypertension vaccine is complicated by the multi-factorial etiology of hypertension. The renin–angiotensin–aldosterone system (RAAS) is probably the most important regulator of systemic blood pressure and believed to be a major factor in hypertension onset. The RAAS cascade begins with the biosynthesis of the glycoprotein enzyme, renin, in the juxtaglomerular cells of the renal afferent arterioles. Renin cleaves angiotensinogen to form the decapeptide angiotensin-I (AngI). AngI is then further cleaved by angiotensin converting enzyme (ACE), a dipeptidyl carboxypeptidase, to produce an octapeptide, angiotensin- II (AngII). AngII can then bind to angiotensin type 1 (AT-1) receptors and type 2 (AT-2) receptors to initiate a myriad of downstream signalling pathways. The effects of the AT-1 receptor include vasoconstriction, aldosterone synthesis and secretion, increased vasopressin secretion, cardiac hypertrophy, augmentation of peripheral noradrenergic activity, vascular smooth muscle cell proliferation, decreased renal blood flow, renal renin inhibition and renal tubular sodium reuptake. AT-2 receptors are more abundant in the fetus and neonate, suggesting a role in embryonic development and a possible vasodilatation effect. ACE inhibitors (captopril, enalapril, benazepril, ramipril and trandolapril), AngII receptor blockers (irbesartan, candesartan, valsartan and losartan) and direct renin inhibitors (aliskiren) have all successfully been used to reduce high blood pressure (6).

Both ACE inhibitors and AngII receptor blockers have been on the market for many years, and there is evidence to support their benefits beyond blood pressure control. In particular, such agents have been demonstrated to improve the ejection fraction in patients with congestive heart failure, to reduce the levels of urine protein in diabetic patients and prevent recurrent strokes. Vaccines targeting renin, AngI, AngII and AT-1 receptors are currently under development, only two of which are inhuman clinical trial phase, PMD3117 (AngI vaccine) and CYT006-AngQb (AngII vaccine). Not all primary hypertension is expected to respond well to RAAS blockage therapy. Low-renin-level hypertension, a sub-group of primary hypertension, comprises nearly 25% of all primary hypertension cases and is found more frequently in blacks and in the elderly. The etiology of increased blood pressure in this group is probably due to a salt-sensitive phenotype. Interestingly, Aliskiren (a direct renin inhibitor) failed to lower blood pressure in patients who have low renin levels (1).

While only 35% of patients are able to achieve adequate control of their blood pressure levels through traditional therapeutic interventions, this proportion can be improved by the use of a long-acting (4 – 6 months) medication. The current renin vaccine is limited by the fact that it can induce autoimmune deposits. . Vaccines against angiotensin I, angiotensin II and angiotensin II type 1 receptor have shown promising results and good short-term safety profiles.

Two main obstacles towards development of novel hypertension vaccinations are:

(1) A need to prove superiority to the current oral RAAS blockade agents.

(2) A need to demonstrate the long-term safety profile (6).

Several classes of medications, collectively referred to as antihypertensive drugs, are currently available for treating hypertension. Reduction of the blood pressure by 5 mmHg can decrease the risk of stroke by 34%, of ischemic heart disease by 21%, and reduce the likelihood of dementia, heart failure, and mortality from cardiovascular disease. The aim of treatment should be reduce blood pressure to <140/90 mmHg for most individuals, and lower for individuals with diabetes or kidney disease (some medical professionals recommend keeping levels below 120/80 mmHg). If the blood pressure goal is not met, a change in treatment should be made as therapeutic inertia is a clear impediment to blood pressure control. Comorbidity also plays a role in determining target blood pressure, with lower BP targets applying to patients with end-organ damage or proteinuria. The first line antihypertensive supported by the best evidence is a low dose thiazides diuretic. Often multiple medications in combined are needed to achieve the goal blood pressure. Commonly used prescription drugs include: ACE inhibitors, alpha blockers, angiotensin II receptor antagonists, beta blockers, calcium channel blockers, diuretics (e.g. hydrochlorothiazide), direct renin inhibitors. Some examples of common combined prescription drug treatments include: A fixed combination of an ACE inhibitor and a calcium channel blocker. One example of this is the combination of perindopril and amlodipine, the efficacy of which has been demonstrated in individuals with glucose intolerance or metabolic syndrome (1).

ffiris pharmaasia is starting a development program for vaccination against hypertension. The vaccine will be based on the company’s own Affitome technology. However, for the first time it is now being used against a human hormone. The reason for this announcement is the approval of significant development funds by the Austrian Research Promotion Agency, FFG. The vaccine is targeting angiotensin II. CSO Dr Frank Mattner states that although chronic hypertension can be treated with drugs, the patient has to be precisely attuned to them and must then take medication constantly which often doesn’t work out. Their vaccine is intended to lower the burden of strictly following this medication dictate, thereby contributing to ensuring lasting success. Taking into account the long term aspect of hypertension leads to the often fatal sequelae such as heart diseases, stroke and kidney problems in the long term, sustainability is key for treatment’s success.

The idea of intervening in the body hormone regulation of blood pressure by means of a vaccine arose in recent years. Dr Walter Schmidt, CEO of Affiris explains that in order to develop a vaccine that can reduce hypertension, it must be able to trigger a highly specific immune response. The blood pressuring – increasing angiotensin II and the blood pressure reducing angiotensin 1-7 differ by only one amino acid, while the remainder of the structure is identical. Their Afitome technology allows us to adjust the immune response such that only angiotensin II is addressed.

Cytos Biotechnology Ltd (SIX:CYTN) Schlieren (Zurich), Switzerland gave an update on the development of its hypertension vaccine CYT006-AngQb. In a first phase IIa study the vaccine was safe, well tolerated and efficacious in lowering the mean ambulatory blood pressure by -9/-4 mmHg (systolic/diastolic) vs. placebo. The immune system generates over time antibody responses of increased affinities by selectively expanding those B-cells which get best access to the antigen through binding via surface bound high affinity antibodies. Those B-cell clones that bind the antigens best are selectively expanded at the expense of those clones that bind them weakly. If too much antigen is delivered too quickly, predominantly weakly binding antibodies may be expanded at the expense of those binding well. This could have happened in their studies second and third. The conclusions drawn from the results of the three studies are that the altered treatment regimen of studies second and third reproducibly lead to qualitatively different antibody responses with a significantly lower affinity than the conventional treatment regimen of study first. Furthermore, antibody affinity, which is of critical importance in cases where small target molecules like angiotensin II (8 aminoacids) are to be neutralized, can potentially be controlled by adjusting like the timing of booster injections. Cytos Biotechnology has therefore decided to continue its R&D program in hypertension. About the hypertension vaccine CYT006-AngQb CYT006-AngQb is a therapeutic vaccine in development for the treatment of hypertension. It is designed to instruct the patient’s immune system to produce an antibody response against angiotensin II. Angiotensin II is a small peptide in the body and part of the rennin angiotensin system (RAS), which is an important regulator of blood pressure. Angiotensin II causes blood vessels to narrow, resulting in increased blood pressure. In a phase IIa study with hypertensive patients, vaccination with CYT006-AngQb has been shown to significantly reduce the mean ambulatory daytime blood pressure by induction of antibodies that bind angiotensin II (The Lancet 2008, 371:821). A particularly strong blood pressure reduction has been observed in the early morning hours – a crucial time of day when adverse cardiovascular events are more likely to occur than during other times of the day. CYT006-AngQb is a first-in-class product candidate in this important indication and represents a completely novel approach to hypertension treatment. Treatment with CYT006-AngQb should allow for convenient dosing schedules and a smooth control of blood pressure due to a sustained antibody response induced by vaccination (4)

Medicine is changing. The revolution in medicine has fundamentally altered our notions of disease etiology and classification, and promises novel therapeutic interventions. Several classes of medications, collectively referred to as antihypertensive drugs, are currently available for treating hypertension. The creation of a vaccine against hypertension promises to eliminate the problems associated with conventional pharmacological agents, including noncompliance with daily dosing schedules, undesirable side effects and drug-drug interactions, and irregular, short-acting and ineffective diurnal blood pressure control.

There are a lot of systems integrators that are advertised online these days and just do not know that their claims are met or not. HCG quickly became a sensation in the world of weight loss, but there are some things that need to be cleared. HCG drops, one of the products of HCG is produced using the hormone produced in a body when the pregnant woman, but is this safe for men, too?

Fact 1: HCG drops will not adversely affect men.Might be a misconception by some that simply because the hormone human chorionic gonadotropin, or HCG is located on the uterus of a woman who is dangerous for men to take. The fact is that hCG drops not only in the body of a pregnant woman, but at some point in the body of men as well. Because HCG is produced to keep the development of embryos, if the mother is carrying a male fetus, so technically that has absorbed the hormone as well to the uterus. The men would not have not developed some of their masculine organs without HCG.

Fact 2: HCG affects older men in the same way. This hormone promotes the production of testosterone and is really from where comes the HCG drops. Dr. A.t. Simeons HCG given to boys attained from Froelich’s syndrome. This syndrome is characterized by obesity, delayed puberty, stature and growth retardation. He found that the hormone helped develop sexual organs, lose weight and less hunger. After this discovery was born HCG drops.

Fact 3: HCG drops as a weight loss tool does not run the risk of overdose. HCG can reach international levels of over 288,000 units. Measurement is the height that HCG in the body of a pregnant woman and has no negative effect for both the mother and embryo growth. HCG injections contain 125 IU which is much less to its peak levels. It is only the required level for losing weight, it is certainly not a danger. HCG drops then contain everything you need to start the effects of weight loss and no more.

Fact 4: men have had success with Drops .there HCG weight loss were without problems or indications of the negative effects of men who lose weight through the use of HCG drops. In fact, men who are on the HCG diet are throwing off fat and weight faster than women.

For people who suffer from this common skin disease eczema remedies may relieve constant irritation. Home remedies to treat facial eczema are very easy to follow and the beauty is that all ingredients are available in your kitchen. If it is party.

1. you can also try evening primrose oil. This herb has been mixed, how to be effective in the treatment of itching associated with eczema. Some patients swear by it, then others will not notice much effect. It is important to remember that the herbs work differently on different people, and that certain remedies may work for some people and not work for others. Plant essential oils, for the first time a small amount on your hand to see if you have an allergic reaction.

2. If the skin is completely raw and angry because the outbreak of eczema, adding topical ointments can cause the skin to burn and become more irritated. In this particular case, it might be a better idea to take herbal supplements that can work to relieve the symptoms internally. You can try a herbs such as grape seed extract, which is an anti-inflammatory herb medicines taken by mouth that will help you control your eczema.

3. This natural product derived from neem leaves a great antiseptic properties. You can use mixed with the cream for the face or masks. There are others, such as vitamin E oil, coconut oil and Virgin olive oil in calming facial sci affected by eczema. Topical application of these oils done wonders in the process of effective treatment.

4. it is essential to provide a calming sensation to keep your skin moisturized using ointments containing herbal ingredients for your skin. Be sure to buy one that contains aloe vera or witch hazel that studies have proven to be effective in reducing swelling and irritation. When you apply the ointment region affected, not to scratch the affected area because this can cause an infection.

5 you know something as simple as taking a lot of high-fiber foods greatly improve skin conditions? You can also try to avoid fatty foods and milk acids foods products lie. These simple tips are really incredible result to alleviate the problem.

200 g of Boil 6 mustard oil in an iron container. In boiling oil, add 50 grams of neem leaves his Office. When the leaves become black, stop heating, cooling oil and screens. Apply this oil 4 times per day. If applied during one year the problem never reoccur. It is a good natural remedy for eczema.

7 Grid a large block of SOAP olive or vegetable oil in a basin and add 25 grams of finely chopped grass, a few drops of essential oil and a spoonful of tablespoon finely ground oatmeal. Heat gently until they melt and mix well. Take any box or the egg mold with greaseproof paper and SOAP in it. Use this SOAP for face cleaning.